CD8A and breast carcinoma: To substantiate that enrichment of CD39+PD-1+CD8+ T cells is the key immunological difference between 4T07 and 4T1 breast cancers, we analyzed our high-dimensional flow cytometry data using the unbiased representation-learning algorithm CellCnn33,34.